Suspended

Efficacy of Internet and Smartphone Application-delivered TRT

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Ginkgo biloba

+ Ginkgo biloba

+ modified TRT

DrugBehavioral
Who is being recruted

Ear Diseases+6

+ Hearing Disorders

+ Nervous System Diseases

From 20 to 65 Years
+2 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: September 2014
See protocol details

Summary

Principal SponsorSeoul National University Hospital
Last updated: October 25, 2016
Sourced from a government-validated database.Claim as a partner

Study start date: September 1, 2014

Actual date on which the first participant was enrolled.

to investigate the effect of TRT with minimized counseling

NCT01663467
Principal SponsorSeoul National University Hospital
Last updated: October 25, 2016
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 20 to 65 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Ear DiseasesHearing DisordersNervous System DiseasesNeurologic ManifestationsOtorhinolaryngologic DiseasesSensation DisordersSigns and SymptomsPathological Conditions, Signs and SymptomsTinnitus

Criteria

1 inclusion criteria required to participate
chronic subjective tinnitus
1 exclusion criteria prevent from participating
THI < 18

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Active Comparator
control group Ginexin-F 80mg tablet will be given twice a day for 6 months.

Group II

Experimental
experimental group modified TRT (tinnitus retraining therapy) using smartphone and web based materials will be added with Ginkgo biloba. Ginexin-F 80mg tablet will be given twice a day for 6 months.

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Seoul National University Hospital

Seoul, South KoreaOpen Seoul National University Hospital in Google Maps
SuspendedOne Study Center